Alpha Cognition Inc.
ACOGNasdaq
$8.50
↑ +1.8%Jul 17 close · end-of-day
Price
1Y↓ -18.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$186.4M
Enterprise Value
$132.1M
P/E
—
P/S
17.2
P/B
3.2
EV/EBITDA
—
PEG
—
FCF Yield
-16.3%
Dividend Yield
—
Revenue (TTM)
$10.8M
Net Income (TTM)
-$25.4M
Free Cash Flow (TTM)
-$30.4M
Gross Margin
—
Operating Margin
-252.7%
Net Margin
-234.8%
ROE
-44.3%
ROIC
-673.5%
Debt / Equity
—
Net Cash
$54.2M
Return 1Y
-17.2%
Company profile
The Company is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease, for which there are limited or no treatment options. Alpha Cognition Canada Inc. became the Company’s wholly-owned subsidiary. Our principal executive offices are located at 1200 – 750 West Pender Street, Vancouver, British Columbia. Our offices in the United States are located at 20073 Fiddler’s Green, Frisco, Texas.
- CEO
- Michael McFadden
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Headquarters
- Texas
- Website
- www.alphacognition.com
Management & directors
- D'Angelo LaurenChief Operating Officer
- Du Henry HuyVP Finance and Accounting
- Mcfadden Michael E.Chief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
ACOG Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$3.5M↑ +20.7%
Diluted EPS-$0.32↑ +190.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | — | — | $10.2M |
| Gross profit | — | — | — |
| Operating income | -$9.9M | -$12.0M | -$22.7M |
| Net income | -$13.8M | -$14.8M | -$20.7M |
| Diluted EPS | -$3.84 | -$2.04 | -$1.18 |
| Operating cash flow | -$8.8M | -$7.8M | -$20.4M |
| Free cash flow | — | -$7.8M | -$20.7M |
| Gross margin | — | — | — |
| Operating margin | — | — | -221.7% |
| Net margin | — | — | -202.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $2.9M | $1.7M | $2.8M | $2.8M | $3.5M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$2.4M | -$2.5M | -$2.7M | -$3.4M | -$5.7M | -$5.3M | -$8.2M | -$8.1M |
| Net income | -$2.1M | -$1.9M | -$5.8M | -$1.7M | -$10.5M | -$1.3M | -$7.1M | -$6.5M |
| Diluted EPS | -$0.35 | -$0.31 | -$0.51 | -$0.11 | -$0.65 | -$0.30 | -$0.12 | -$0.32 |
| Operating cash flow | -$1.4M | -$1.6M | -$2.3M | -$2.0M | -$6.1M | -$5.3M | -$6.9M | -$11.8M |
| Free cash flow | — | — | — | -$2.1M | -$6.1M | -$5.4M | -$7.1M | -$11.8M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | -116.3% | -346.1% | -187.0% | -293.8% | -229.1% |
| Net margin | — | — | — | -58.9% | -632.7% | -46.4% | -255.6% | -183.3% |
Company news
Jun 23, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-26 | Opaleye Management Inc. | Buy | 152,336 | $6.40 | $975,209.37 | filing |
| 2026-06-25 | Opaleye Management Inc. | Buy | 197 | $6.50 | $1,280.50 | filing |
| 2026-06-15 | Opaleye Management Inc. | Buy | 4,550 | $5.99 | $27,252.68 | filing |
| 2026-06-12 | Opaleye Management Inc. | Buy | 273 | $5.93 | $1,619.46 | filing |
| 2026-06-11 | Opaleye Management Inc. | Buy | 2,862 | $5.91 | $16,900.97 | filing |
| 2026-06-10 | Opaleye Management Inc. | Buy | 5,872 | $5.99 | $35,157.43 | filing |
| 2026-06-09 | Opaleye Management Inc. | Buy | 24,856 | $5.98 | $148,534.48 | filing |
| 2026-06-05 | Opaleye Management Inc. | Buy | 10,054 | $5.83 | $58,595.72 | filing |
| 2026-05-29 | Opaleye Management Inc. | Buy | 70,577 | $5.90 | $416,397.24 | filing |
| 2026-05-28 | Opaleye Management Inc. | Buy | 2,000 | $5.83 | $11,664.00 | filing |
| 2026-05-27 | Opaleye Management Inc. | Buy | 1,161 | $5.73 | $6,652.53 | filing |
| 2026-05-21 | Opaleye Management Inc. | Buy | 15,945 | $5.70 | $90,886.50 | filing |
| 2026-05-20 | Opaleye Management Inc. | Buy | 8,431 | $5.89 | $49,658.59 | filing |
| 2026-05-19 | D'Angelo Lauren· Chief Operating Officer | Buy | 3,500 | $5.76 | $20,160.00 | filing |
| 2026-05-18 | Opaleye Management Inc. | Buy | 17,395 | $5.69 | $99,022.78 | filing |
| 2026-05-15 | Opaleye Management Inc. | Buy | 16,648 | $5.83 | $96,986.25 | filing |
| 2026-04-16 | Sensenig Bethany | Award | 5,489 | $0.00 | $0.00 | filing |
| 2026-03-30 | Opaleye Management Inc. | Buy | 1,850 | $4.99 | $9,226.51 | filing |
| 2026-03-27 | Opaleye Management Inc. | Buy | 10,000 | $5.08 | $50,792.00 | filing |
| 2026-03-26 | Opaleye Management Inc. | Buy | 7,319 | $5.28 | $38,675.06 | filing |
| 2026-03-25 | Opaleye Management Inc. | Buy | 8,581 | $5.43 | $46,578.53 | filing |
| 2026-03-24 | Opaleye Management Inc. | Buy | 4,182 | $5.59 | $23,377.38 | filing |
| 2026-03-19 | Opaleye Management Inc. | Buy | 2,094 | $5.71 | $11,950.46 | filing |
| 2026-03-18 | Opaleye Management Inc. | Buy | 2,481 | $5.75 | $14,263.27 | filing |
| 2026-03-16 | Opaleye Management Inc. | Buy | 1,331 | $5.78 | $7,695.84 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.